PDF) Metronomic capecitabine as extended adjuvant chemotherapy in women with triple negative breast cancer
Cancers | Free Full-Text | Metronomic Chemotherapy
Metronomic chemotherapy in breast cancer | Semantic Scholar
JCM | Free Full-Text | Metronomic Chemo-Endocrine Therapy (FulVEC) as a Salvage Treatment for Patients with Advanced, Treatment-Refractory ER+/HER2- Breast Cancer—A Retrospective Analysis of Consecutive Patients Data
Grade 3-5 adverse events in patients with advanced breast cancer... | Download Scientific Diagram
A phase II study of a doublet metronomic chemotherapy regimen consisting of oral vinorelbine and capecitabine in Chinese women with HER2-negative metastatic breast cancer,Thoracic Cancer - X-MOL
Metronomic Chemotherapy for Breast Cancer
Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial - ScienceDirect
Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center - Lu - 2020 - Cancer Communications - Wiley Online Library
Frontiers | Gut Microbiota Profiling in Patients With HER2-Negative Metastatic Breast Cancer Receiving Metronomic Chemotherapy of Capecitabine Compared to Those Under Conventional Dosage
Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01) | Journal of Clinical Oncology
Safety and efficacy study of metronomic vinorelbine, cyclophosphamide plus capecitabine in metastatic breast cancer: A phase II trial. | Semantic Scholar
JAMA Oncology on X: "Ph 2 trial of metronomic oral chemo w/vinorelbine, cyclophosphamide, & capecitabine (VEX) regimen vs weekly paclitaxel for pts.w/hormone receptor-pos, HER2-neg adv #BreastCancer showed superior time to treatment failure w/VEX ...
Low-Dose Xeloda After Surgery for Triple-Negative Breast Cancer Reduces Recurrence Risk - CancerConnect
Targeted Oncology on LinkedIn: Metronomic Capecitabine Continues Efficacy With Pyrotinib in HER2+…
Program Guide – ASCO Meeting Program Guide
Metronomic capecitabine maintenance extends DFS in triple-negative breast cancer
Elderly Woman with Triple-negative Metastatic Breast Cancer Successfully Treated with Metronomic Capecitabine | Anticancer Research
Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis
Frontiers | Cost-effectiveness analysis of metronomic capecitabine as adjuvant chemotherapy in locoregionally advanced nasopharyngeal carcinoma
Lapatinib and metronomic capecitabine combination in an HER2-positive inflammatory breast cancer patient: a case report - Annals of Oncology
Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial) | Future Oncology
![PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/957fa2625a87315f5d56f5911f5b8b269f747b86/6-Table2-1.png "PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar")
PDF] Treating advanced breast cancer with metronomic chemotherapy: what is known, what is new and what is the future? | Semantic Scholar
Capecitabine metronomic chemotherapy inhibits the proliferation of gastric cancer cells through anti-angiogenesis
